Aprea Therapeutics, Inc. - APRE
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$1.891M
QoQ value delta ($000)
$0
(0.0%)
Implied price effect (QoQ)
-0.0%
Shares
Total shares
2,370,849
QoQ shares delta
+40
(+0.0%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (APRE)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| AIGH Capital Management LLC | 814 | 1,015,541 | 0.05% |
| Vestal Point Capital, LP | 280 | 350,000 | 0.01% |
| SPHERA FUNDS MANAGEMENT LTD. | 216 | 270,000 | 0.03% |
| Nantahala Capital Management, LLC | 165 | 205,760 | 0.01% |
| RENAISSANCE TECHNOLOGIES LLC | 84 | 105,800 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 60 | 74,869 | 0.0% |
| CITADEL ADVISORS LLC | 47 | 58,600 | 0.0% |
| BNP PARIBAS FINANCIAL MARKETS | 36 | 45,211 | 0.0% |
| DIADEMA PARTNERS LP | 36 | 44,907 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 30 | 38,464 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28 | 34,939 | 0.0% |
| MORGAN STANLEY | 20 | 25,830 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 18 | 22,882 | 0.0% |
| LPL Financial LLC | 12 | 16,052 | 0.0% |
| HighTower Advisors, LLC | 11 | 13,864 | 0.0% |
| NORTHERN TRUST CORP | 10 | 13,705 | 0.0% |
| Persistent Asset Partners Ltd | 9 | 11,490 | 0.0% |
| XTX Topco Ltd | 8 | 10,565 | 0.0% |
| BlackRock, Inc. | 5 | 7,173 | 0.0% |
| Tower Research Capital LLC (TRC) | 2 | 3,590 | 0.0% |
| BARCLAYS PLC | 0 | 473 | 0.0% |
| FMR LLC | 0 | 45 | 0.0% |
| GROUP ONE TRADING LLC | 0 | 577 | 0.0% |
| UBS Group AG | 0 | 3 | 0.0% |
| OSAIC HOLDINGS, INC. | 0 | 295 | 0.0% |